ask="20.10"
ask_size="100"
average_daily_volume="439257"
bid="16.26"
bid_size="200"
book_value="3.21"
change="-0.91"
change_from_200_day_moving_average="4.38"
change_from_50_day_moving_average="-0.57"
change_from_52_week_high="-3.98"
change_From_52_week_low="13.75"
change_in_percent="-4.40%"
close="19.77"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.48"
ebitda="-21.87M"
eps_estimate_current_year="-2.59"
eps_estimate_next_quarter="-0.59"
eps_estimate_next_year="-2.48"
ex_dividend_date="N/A"
float_shares="7150000"
high="20.80"
high_52_weeks="23.75"
last_trade_date="3/16/2017"
last_trade_price="19.77"
last_trade_size="2208"
last_trade_time="4:00pm"
low="19.62"
low_52_weeks="6.02"
market_capitalization="196.77M"
moving_average_200_day="15.39"
moving_average_50_day="20.34"
name="Zynerba Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="30.63"
open="20.63"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+28.50%"
percent_change_from_50_day_moving_average="-2.78%"
percent_change_from_52_week_high="-16.76%"
percent_change_from_52_week_low="+228.41%"
previous_close="20.68"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.45"
price_per_sales="3641.43"
revenue="56524.00"
shares_outstanding="9953000"
short_ratio="3.71"
stock_exchange="NGM"
symbol="ZYNE"
volume="306629"
weeks_range_52="6.02 - 23.75"
